Needham analysts said Teleflex’s inability to secure a price above the low end of their expectations could reflect “the continued poor performance of UroLift.” ...

Medical device maker Teleflex said on Tuesday it would sell three units for a combined $2.03 billion, as it sharpens its focus on its critical care and hospital businesses. Shares of the company were ...

Wondering if Teleflex is a beaten down opportunity or a value trap at today’s price? Let us walk through what the numbers are really saying about the stock. After sliding 3.8% over the last week, ...

Teleflex (TFX) has agreed to sell its acute care, interventional urology and OEM businesses to two buyers for a combined $2.03 billion in cash, subject to adjustments. Intersurgical will acquire the ...

The OEM arm is sold to private equity firms Montagu and Kohlberg, while UK-based Intersurgical will take over the other two divisions in $2B deal.

Teleflex said it plans to sell three of its businesses for a total of $2.03 billion in cash as it continues to focus on its core markets.

Shares of medical technology company Teleflex (NYSE:TFX) fell 22.9% in the morning session after the company reported disappointing fourth-quarter results, with revenue missing expectations by a ...

CAUTION: Federal (USA) law restricts these devices for sale or use by or on the order of a physician.

Teleflex stock (NYSE: TFX), best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a 31% fall this year, underperforming the broader S&P500 index, ...

The what, where, when, why and how was known, but the who behind a new, roughly 150-employee medical device research facility being built on former VF Outlet Center property in Wyomissing was the big ...

The stock price of Teleflex, best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a decline of 12% over the last month, while it was down over 4% ...